Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
01 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/01/3108190/0/en/BioXcel-Therapeutics-Receives-Second-Positive-Recommendation-from-Data-Safety-Monitoring-Board-DSMB-to-Continue-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of.html
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088584/0/en/BioXcel-Therapeutics-Receives-Positive-Recommendation-from-Data-Safety-Monitoring-Board-DSMB-to-Continue-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of-Agitat.html
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088455/0/en/BioXcel-Therapeutics-Granted-Extension-to-Regain-Compliance-with-Nasdaq-Continued-Listing-Requirement.html
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3078977/0/en/BioXcel-Therapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050402/0/en/BioXcel-Therapeutics-Reports-Financial-Results-for-the-Fourth-Quarter-and-Full-Year-2024.html
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040398/0/en/BioXcel-Therapeutics-Strengthens-Cash-Position-to-Advance-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of-Agitation-Associated-with-Bipolar-Disorders-or-Schizo.html
ABOUT THIS PAGE